Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Rituximab (Rituxan) on B Cell and AMA Response in Patients With Primary Biliary Cirrhosis

NCT00364819 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.

NCT NCT00364819
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00364819 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Rituximab (Rituxan) on B Cell and AMA Response in Patients With Primary Biliary Cirrhosis
Lead sponsor
University of California, Davis
Phase
Phase 1/2
Overall status
Completed
Start date
January 31, 2007
Completion date
December 31, 2009
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary biliary cirrhosis